Seletracetam

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSeletracetam
Drug Alias Name塞曲西坦seletracetamumUCB-44212
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicle glycoprotein 2A modulators
TargetsSynaptic vesicle glycoprotein 2A
Therapy Area/IndicationsEpilepsies, PartialEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUcb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsEpilepsies, PartialEpilepsy

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG